I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
May 14, 2023 at 10:38 pm EDT
Share
i-SENS, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 60,647.08 million compared to KRW 68,823.18 million a year ago. Net income was KRW 4,214.1 million compared to KRW 13,000.53 million a year ago.
Basic earnings per share from continuing operations was KRW 153 compared to KRW 475 a year ago. Diluted earnings per share from continuing operations was KRW 153 compared to KRW 474 a year ago. Basic earnings per share was KRW 153 compared to KRW 475 a year ago.
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
I-SENS, INC. 
